Therapeutic efficacy and clinical acceptability of fusafungine in follicular pharyngitis

Current Medical Research and Opinion

Volumn 18, Issue 7, 2002, Pages 381-388

  Pandraud, L ^a  

^a Centre Hospitalier de Saint Cloud   (France)

Author keywords

Double blind study; Follicular pharyngitis; Fusafungine; Placebo; Randomized

Indexed keywords

FUSAFUNGINE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PHARYNGITIS; RANDOMIZED CONTROLLED TRIAL; SYMPTOMATOLOGY; TREATMENT OUTCOME;

ADMINISTRATION, INHALATION; ADMINISTRATION, INTRANASAL; ADULT; AEROSOLS; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CHI-SQUARE DISTRIBUTION; DOUBLE-BLIND METHOD; FEMALE; FUSARIUM; HUMANS; MALE; MIDDLE AGED; PHARYNGITIS; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 0036453526     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079902125001173     Document Type: Article

References (36)

1. Schroeder HG. Die pharyngitis und ihre verschiedenen klinischen erscheinungsformen. [Pharyngitis and its various clinical manifestations]. Ther Umsch 1995;52:749-54
2. Tarasov DI, Morozov AB. Chastota i struktura khronicheskikh zabolevanii ukha, gorla i nosa sredi naselenia i ikh dinamika. [Frequency and structure of chronic diseases of ear, throat and nose among population and their dynamics] Vest Otorinolaringol 1991;2:12-14
3. Pandraud L. La pharyngite granuleuse. Gaz Méd 1993;23:40-3
4. Bouche J, et al. Classification étiopathogénique des pharyngitis chroniques. Ann Otolaryngol 1977;94:121-5
5. Hahn R. Clinical evaluation of flurbiprofen alone and plus ampicillin in chronic pharyngitis in acute phase. Int J Clin Pharmacol Res 1986;6:81-6
6. Hytiroglou P, Brandwein MS, Strauchen JA, Mirante JP, Urken ML, Biller HF. Inflammatory pseudotumor of the parapharyngeal space: Case reports and review of the literature. Head Neck 1992;14:230-4
7. Wenig BM, Devaney K, Wenig BL. Pseudoneoplastic lesions of the oropharynx and larynx simulating cancer. Pathol Annu 1995;30(Pt 1):143-87
8. Bassiouny A, el-Refai HA, Abdel Nabi EA, Fateen AM, Hendawy DS. Candida infection in the tongue and pharynx. J Laryngol Otol 1984;98:609-11
9. Falk G, Heyman L, Gnarpe J, Gnarpe H. Chlamydia pneumoniae and chronic pharyngitis. Scand J Infect Dis 1995;27:179-82
10. Emmanueli JL. Infectious granulomatous diseases of the head and neck. Am J Otolaryngol 1993;1453:155-67
11. Peix JL, Moulin G, Evreux M, Berger N, Magis M. Localizations bucca-pharynges et oesophagienne de la maladie de Crohn. Gastroenterol Clin Bio 1987;11:604-60
12. Sechovic-Duric N. Znacaj izlozenosti radnika zaposlenih u kozarskoj industriji u prevalenciji obojenja gornjih respiratornih puteva [Significance of exposure of workers in the tanning industry and the prevalence of upper respiratory tract diseases]. Med Arh 1992;46:71-2
13. Kanerva L, Makinen-Kiljunen S, Kiistala R, Granlund H. Occupational allergy caused by spathe flower (Spathiphyllum wallisii). Allergy 1995;50:174-8
14. Gluk U. Pollinossis und oral Allergiesyndrom (OAS) [Pollinosis and oral allergy syndrome]. HNO 1990;38:188-90
15. Kremser M. Nahrungsmittelallergien-orpharyngeale reaktionen [Food allergies-oropharyngeal reactions]. Wien Med Wochenschr 1989;139:135-9
16. Drosnes DL, Zwillenberg DA. Laryngeal granulomatous polyp after short-term intubation of a child. Ann Otol Rhinol Laryngol 1990;99:183-6
17. Koltai P. Effects of air pollution on the upper respiratory tract of children. Otolaryngol Head Neck Surg 1994;111:9-11
18. Murthy P, Laing MR. Cigarette smoking and throat pains in adults. Postgrad Med J 1995;71:510[Letter]
19. Cote DN, Miller RH. The association of gastroesophageal reflux and otolaryngologic disorders. Compr Ther 1995;21:80-4
20. Olson NR. Laryngopharyngeal manifestations of gastroesophageal reflux disease. Otolaryngol Clin North Am 1991;24:1201-13
21. Rival R, Wong R, Mendelsohn M, Rosgen S, Goldberg M, Freeman J. Role of gastroesophageal reflux disease in patients with cervical symptoms. Otolaryngol Head Neck Surg 1995;113:364-9
22. Contencin P, Adjoua P, Viala P, Erminy M, Narcy P. La pH-métrie couplée, oesophagienne et oro/hypopharyngée, de longue durée dans les formes ORL de reflux gastrooesophagien de l'enfant. Ann Otolaryngol Chir Cervicofac 1992;109:129-33
23. Pearlman NW, Stiegmann GV, Teter A. Primary upper aerodigestive tract manifestations of gastroesphageal reflux. Am J Gastroenterol 1988;83:22-5
24. Deschner WK, Benjamin SB, Extraesophageal manifestations of gastroesophageal reflux disease. Am J Gastroenterol 1989;84:1-5
25. Trotoux J, Angelard B, Aubert P. Manifestations ORL du reflux gastro-oesophagien. Rev Prat 1989;39:291-3
26. Ward PH, Berci G. Observations on the pathogenesis of chronic non-specific pharyngitis and laryngitis. Laryngoscope 1982;92:1377-82
27. Kibblewhite DJ, Morrison MD. A double-blind controlled study of the efficacy of cimetidine in the treatment of the cervical symptoms of gastroesophageal reflux. J Otolaryngol 1990;19:103-9
28. Zaidi SH. A study of H2 receptor antagonists in the treatment of chronic intractable pharyngitis. Pak Med Assoc 1990;40:217-19
29. Lemercier JP. Locabiotal pressurisé et inflammation bronchique. Etude bronchoscopique et histopathologique. Vie Med 1976;57:2061-3
30. White RR, Mattenberger L, Giessinger N. Activité anti-inflammatoire de la fusafungine: Rôle des macrophages. Drugs Dis/Malad Medicam 1987;3(Suppl 1):57-62
31. Guenant G. Rapidité d'action de locabiotal pressurisé en monothérapie dans les rhino-sinusites débutantes. Drugs Dis/Malad Medicam 1988;4:105-12
32. Gheam A, Harpey C. Evaluation de l'activité anti-inflammatoire de la fusafungine par rhinomanométrie. Etude à double insu contre placebo. Cah Oto-rhino-laryngol 1988;23(Suppl 4):25-8
33. Nolibe D, Delage G, Thang MN. Activité antivirale de la fusafungine. Rhinology 1988;(Suppl 5):37-43
34. Reinert P. Intérêt des test rapides pour la détection des infections streptococciques: Illustration par une étude sur locabiotal pressurisé dans les amygdalites. Malad Medicam 1989;5:97-104
35. German-Fattal M, Le-Roy-Ladurie F, Cerrina J, Lecerf F, Berrih-Aknin S. Modulation of TNF-alpha expression in human alveolar macrophages in vitro by the anti-inflammatory drugs fusafungine and dexamethasone. Eur Respir J 1996;(Suppl. 9):2861
36. Gosset P, Wallaert B, Crambes O, Girard V, Malbezin M, Tonnel AB. Fusafungine inhibits oxidative burst in macrophages during inflammatory response. Eur Respir J 1996;(Suppl 9):2860